Skip to Main Content

Paper Details

LRRC15 antibody-drug conjugates show promise as osteosarcoma therapeutics in preclinical studies.
Pediatr Blood Cancer
5
2021
ADC, LRRC15, LRRC15 ADC, LRRC15 expressing OS cell lines, LRRC15 locus, Leucine, Leucine-rich repeat containing 15, MMAE, OS, OS cell, OS cells, OS human cell lines, OS tumor, OS tumor cells, Osteosarcoma, PNU, PNU-159682, TGF, anthracycline, anthracyclines, bone tumor, cell lines, children, eosin, hematoxylin, human, monomethyl auristatin E, murine, murine xenografts, osteosarcoma, tubulin, tumor
Author NameAffiliation
Paul S MeltzerCenter for Cancer Research, National Cancer Institute
Paul S MeltzerCenter for Cancer Research, National Cancer Institute
Lee J HelmanChildren's Hospital Los Angeles
Lee J HelmanUniversity of Southern California
Lee J HelmanChildren's Hospital Los Angeles
Lee J HelmanUniversity of Southern California
  • 1 - 6

Datasets

Release 1.2